AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Integra LifeSciences Holdings
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S7JWM6
11.91▼ 0.41 (-3.37%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
12.33
Day's Range
11.82 – 12.40
52-Week Range
8.70 – 20.49
Volume
1.2M
Avg Volume
1.1M
Share Statistics
Shares Outstanding
Employees
4,427
Exchange
XNAS
Listed
1995-08-16
Share count as of July 28, 2026

Integra LifeSciences Holdings (IART) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Integra LifeSciences Holdings (IART)
What is Integra LifeSciences Holdings's Market Cap?
Integra LifeSciences Holdings's Market Cap is $926.3M, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's Enterprise Value?
Integra LifeSciences Holdings's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's Price / Sales?
Integra LifeSciences Holdings's Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's EV / Revenue?
Integra LifeSciences Holdings's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's EV / EBITDA?
Integra LifeSciences Holdings's EV / EBITDA is 11.1×, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's Revenue (TTM)?
Integra LifeSciences Holdings's Revenue (TTM) is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's Net Income (TTM)?
Integra LifeSciences Holdings's Net Income (TTM) is -$7.2M, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's EBITDA?
Integra LifeSciences Holdings's EBITDA is $125.4M, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's Diluted EPS (TTM)?
Integra LifeSciences Holdings's Diluted EPS (TTM) is -0.09, based on as-reported figures from SEC (XBRL) filings.
What is Integra LifeSciences Holdings's EBITDA Margin?
Integra LifeSciences Holdings's EBITDA Margin is 7.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IARTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total revenue, net
YoY growth+0.8%+2.4%-1.7%+5.6%
Costs and expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Intangible asset amortization
Goodwill impairment charge—
Total costs and expenses
% of revenue95.4%97.1%94.7%97.1%
Operating income (loss)
% of revenue4.6%2.9%5.3%2.9%
Interest income
Interest expense
Other income (expense), net
Income (loss) before income taxes
Provision (benefit) for income taxes
Net income (loss)
% of revenue1.1%-1.2%-0.4%-1.3%
Basic (in dollars per share)
Diluted (in dollars per share)